Table 2.
Postischemic metabolic parameters
Tw = 0 min | Tw = 30 min | Tw = 60 min | Tw = 90 min | Tw = 120 min | |
---|---|---|---|---|---|
MVO2 (mL/min/g) Control | 1.3 ± 0.2 | 1.5 ± 0.2* | 1.6 ± 0.3* | 1.7 ± 0.3* | 1.5 ± 0.3 |
Deltorphin D | 1.2 ± 0.2 | 1.7 ± 0.1* | 1.8 ± 0.1* | 1.6 ± 0.1* | 1.4 ± 0.2 |
Cariporide | 1.4 ± 0.1 | 2.0 ± 0.2* | 2.1 ± 0.4* | 2.1 ± 0.2* | 1.8 ± 0.2 |
Lactate µg/min/g) Control | 59 ± 8 | 59 ± 10 | 44 ± 11 | 44 ± 17 | 25 ± 13* |
Deltorphin D | 57 ± 14 | 39 ± 9 † | 24 ± 10* | 15 ± 10* | 27 ± 18* |
Cariporide | 80 ± 10 | 89 ± 21 | 56 ± 19 | 31 ± 7* | 20 ± 7* |
All values are mean ± SE.
Cariporide: 3 µM included in the reperfusion buffer; Control: no reperfusion therapy; Deltorphin D: 1 µM Deltorphin D included in the reperfusion buffer; Tw = 0 min, working mode initiation (∼30 min postreperfusion and Deltorphin D administration); Lactate: lactate efflux across the heart (in µg/min per gram heart weight); MVO2: myocardial oxygen consumption (in mL O2/ min per gram heart weight).
P < 0.05 versus Tw = 0 min (repeated measures ANOVA); †P < 0.05 versus cariporide (ANOVA).